Characteristics of injection drug users derived from a large family study of alcoholism.
- Authors
- Dinwiddie, S H
- Year
- 1997
- Journal
- Comprehensive psychiatry
- PMID
- 9202879
- DOI
- 10.1016/s0010-440x(97)90030-4
Most descriptive studies on injection drug users (IDUs) has used treatment or referral samples. This study uses relatives ascertained through the Collaborative Study on the Genetics of Alcoholism (COGA) to describe patterns of drug use, psychiatric comorbidity, and selected high-risk behaviors among IDUs not ascertained through treatment or other referral networks. Relatives (N = 5,520) of alcoholic probands were administered a semistructured interview, the Semistructured Assessment for the Genetics of Alcoholism (SSAGA), which assesses lifetime psychiatric symptoms and psychoactive substance use. IDUs were compared with these who had never used cannabis more than 20 times or other drugs more than 10 times (minimal drug use group), those who had used cannabis more than 20 times but no other illicit drugs more than 18 times (cannabis users), and those who had used other drugs more than 10 times but who had never injected (other drug users). Compared with other drug users, IDUs reported using more classes of drugs and began drug use at an earlier age. IDUs were significantly more likely to receive diagnoses of antisocial personality disorder (ASPD) and alcohol dependence, and reported elevated rates of suicidal ideas and attempts. IDUs were more likely to report a variety of behavioral difficulties beginning before age 15, and were more likely to engage in high-risk sexual behaviors. Half of the IDUs reported having shared needles; shares were more likely to receive a diagnosis of ASPD, but did not differ on reporting high-risk behaviors. IDUs, regardless of whether selected through treatment, have high lifetime rates of mood disturbance and ASPD, and are likely to have a history of conduct difficulties beginning before age 15 years and to subsequently engage in a variety of other high-risk behaviors.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
No papers in this knowledge base cite this source.
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| SUBSTANCE USE AND SUICIDALITY: SPECIFICITY OF SUBSTANCE USE BY INJECTION TO SUICIDE ATTEMPTS IN A NATIONALLY REPRESENTATIVE SAMPLE OF ADULTS WITH MAJOR DEPRESSION. | Cheek SM et al. | — | 2016 | → |
| STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use. | Khan MR et al. | — | 2015 | → |
| Injection drug use is associated with suicide attempts but not ideation or plans in a sample of adolescents with depressive symptoms. | Liu RT et al. | — | 2014 | → |
| Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs. | Buckingham E et al. | — | 2013 | → |
| Prevalence of psychiatric disorders among young injection drug users. | Mackesy-Amiti ME et al. | — | 2012 | → |
| Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. | Khan MR et al. | — | 2009 | → |
| Incarceration and high-risk sex partnerships among men in the United States. | Khan MR et al. | — | 2009 | → |
| Incarceration and risky sexual partnerships in a southern US city. | Khan MR et al. | — | 2008 | → |
| Effects of race, neighborhood, and social network on age at initiation of injection drug use. | Fuller CM et al. | — | 2005 | → |
| Drug-using women need comprehensive sexual risk reduction interventions. | Latka M | — | 2003 | → |
| Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. | Somlai AM et al. | — | 2003 | → |
| Injection drug use in North America. | Schoener EP et al. | — | 2002 | → |
| Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. | Latka M et al. | — | 2001 | → |